Publications
24 publications
Funding
5 grants
Active
2 grants- PIARG01-0605-230503Modular Switchable mRNAs for Tissue and Cell-Specific mRNA-based TherapiesQatar National Research Fund · 2024–2027
- PINPRP14S-0401-210126An RNA-based therapy for the treatment of familial hypercholesterolemia and atherosclerosisQatar National Research Fund · 2023–2025
Completed grants (3)
- Sub-PI225267-01Evaluation of a myeloid microRNA in atherosclerosisWeill Cornell Medical College/Qatar · 2022–2025 · via Leiden University Medical CenterContract
- PISRA 193564-01Najafi -- MODERNA SRAModernaTX · 2019–2020Contract
- PINPRP8-346-1-072miR-33b in Pancreatic -Cell Dysfunction and LipotoxicityQatar Foundation · 2016–2019
Available technologies
2 technologiesView full WCM portfolio ↗
- MicroRNA Mimics for the Treatment of Cardiometabolic Diseases7266Application filedPoC Data
News mentions
2 mentionsView all WCM news ↗
- The Power of Partnership in InnovationApril 14, 2025
Nearly 200 scientists, investors and industry representatives attended Weill Cornell Medicine’s 2025 Biomedical Innovation Conference April 1, sharing their startup journeys and experiences nurturing biomedical advances into health care products and companies.
- Scientists Pitch Medical Innovations at 2023 Biomedical Business Plan ChallengeJune 16, 2023
Six teams pitched their innovations at the 2023 Biomedical Business Plan Challenge Final Pitch Day competition for $100,000 in prize money, which can be used to help build their company, with the goal of ushering in the next generation of life science innovation and patient care.
Mentoring
1 mentee